Viguié Schmidt & Associés has advised LFB

Viguié Schmidt & Associés advised LFB, which enters into exclusive negotiations with Novartis regarding the proposed sale of CellforCure, a leading pharmaceutical establishment that specializes in the industrialization, process optimization and large scale GMP manufacturing of various cell and gene therapy products for bio-pharmaceutical companies.

Members of the team involved in the transaction:


Download the press release

> Back to all news